Click here to view online. Add this email to your safelist.
AstraZeneca launches integrated genomics approach to transform drug discovery and development
22 April 2016
AstraZeneca and its global biologics research and development arm, MedImmune, today announced an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline.
|
|||||
|
|||||
|
For more information please visit astrazeneca.com. If you would like to unsubscribe please click here. |
